Home
About
Overview
Sharing Data
ORCID
Help
History (66)
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential.
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
SMO mutations confer poor prognosis in malignant pleural mesothelioma.
See All 66 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SMO mutations confer poor prognosis in malignant pleural mesothelioma.
SMO mutations confer poor prognosis in malignant pleural mesothelioma. Transl Lung Cancer Res. 2020 Oct; 9(5):1940-1951.
View in:
PubMed
authors with profiles
Marina Chiara Garassino